Matinas Biopharma Holdings, Inc. (MTNB) Q1 2023 Earnings Call

Investor webinar replay

Replay transcript excerpt

Greetings and welcome to the Matinas Biopharma first quarter 2023 conference call and webcast. At this time, all participants are in listen-only mode. A brief question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Jody Kane. Thank you, Jody. You may begin. This is Jody Cain with LHA. Thank you for participating in today's call. Speaking on today's call from Matinas Biopharma will be Jerry DeBoer, Chief Executive Officer, Dr. Terry Makowitz, Chief Development Officer, Dr. Terry Ferguson, Chief Medical Officer, and Keith Kaczynski, Chief Financial Officer. I'd like to remind listeners that remarks made during this call may state management's future intentions hopes, beliefs, expectations, or projections. These are forward-looking statements and involve risks and uncertainties. Forward-looking statements are made pursuant to the safe harbor provisions of the federal securities laws. These forward-looking statements are based on Matinas Biopharma's current expectations and actual results could differ materially. As a result, you should not place undue reliance on any forward-looking statements. Some of the factors that could cause actual results to differ materially from those contemplated by such forward-looking statements are discussed in the periodic reports Bettina's Biopharma files with the Securities and Exchange Commission. These documents are available in the investor section of the company's website and on the SEC's website. Furthermore, the content of this conference call contains information that is accurate only as of the date of the live b...